Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain activ... Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.220599 | 37.8775105125 | 0.582401 | 0.8499 | 0.582401 | 24505 | 0.70758547 | CS |
4 | 0.155 | 23.9197530864 | 0.648 | 0.8499 | 0.5 | 11596 | 0.67879014 | CS |
12 | -0.227 | -22.0388349515 | 1.03 | 1.13 | 0.5 | 9335 | 0.77374781 | CS |
26 | -0.297 | -27 | 1.1 | 1.87 | 0.5 | 12087 | 1.26624852 | CS |
52 | -1.027 | -56.1202185792 | 1.83 | 1.98 | 0.5 | 11721 | 1.15879165 | CS |
156 | -7.117 | -89.8611111111 | 7.92 | 9.4 | 0.5 | 48639 | 5.32812281 | CS |
260 | -10.197 | -92.7 | 11 | 19.56 | 0.5 | 397620 | 11.23385259 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.